About Index Trending news
Lists
Pricing
GSK

GSK

GSK

We’re a science-led global healthcare company on a mission to help people to do more, feel better, live longer. Twitter code of conduct on our site

Elsewhere

Alexa global traffic share

Twitter followers

Investment profile

Geographical Focus
Markets focus
Health and Wellness Health Care Biotechnology Pharmaceuticals
Stage Focus

Activity

Past year's investments

GlaxoSmithKline participated in fewer than 3 rounds over the past year

Latest rounds
  • CRISPR Therapeutics: Venture capital (Series B) ($64M)
  • ZappRx: Venture capital (Series A) ($5.6M)
  • Ionis Pharma: Venture capital ($11M)
Main Co-investors
Total funding
$32.6M in 4 rounds from 14 investors
By GlaxoSmithKline
$5.6M Series A in Apr, 2015
Total funding
$115.9M in 7 rounds from 18 investors
By GlaxoSmithKline
$30.6M Series A in Aug, 2013
Total funding
$43.5M in 3 rounds from 7 investors
By GlaxoSmithKline
$4M Venture capital in Oct, 2011
Total funding
$11M in 1 rounds from 1 investors
By GlaxoSmithKline
$11M Venture capital in Jul, 2014
Total funding
$129.4M in 1 rounds from 1 investors
By GlaxoSmithKline
$129.4M Private equity in Nov, 2010
Total funding
$158M in 3 rounds from 11 investors
By GlaxoSmithKline
$64M Series B in Apr, 2015
Total funding
$46.8M in 2 rounds from 8 investors
By GlaxoSmithKline
$18.4M Series A in Dec, 2012

Want to see the complete list?
Go Pro!